From Science to Practice: Senzime Obtains FDA 510(k) Clearance for Enhanced TetraGraph System
Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that its TetraGraph® neuromuscular monitoring system has received an additional FDA Class II 510(k) clearance. The new FDA clearance follows submission in April 2026 and expands the system's capabilities, further strengthening the TetraGraph's competitive advantages. The new 510(k) clearance includes, among other things, unique capabilities of the next-generation TetraGraph system, and...
Read more









